UK NICE squares up to Australian PBAC, is the US ripe for NICE? News item 30 January 2013 Pages: 2 - 2
Extended UK nurse and pharmacist prescribing powers justified? News item 30 January 2013 Pages: 5 - 5
Which cervical cancer screening strategy best in developing world? Clinical study 30 January 2013 Pages: 5 - 5
Inconsistencies between prescribed antihypertensives and guidelines Clinical study 30 January 2013 Pages: 6 - 6
Shorter duration of antibacterial therapy not costly in CAP Clinical study 30 January 2013 Pages: 7 - 7
Voriconazole dominates liposomal amphotericin B in aspergillosis Clinical study 30 January 2013 Pages: 8 - 8
Metal on metal hip resurfacing “extremely cost-effective” Clinical study 30 January 2013 Pages: 9 - 9
Experimental chemo more cost effective than standard therapy Clinical study 30 January 2013 Pages: 10 - 10
Hypothetical vaccination during flu pandemic cost saving Clinical study 30 January 2013 Pages: 10 - 10
Fall in flu jabs may have been fatal for Japanese kids Epidemiology population study 30 January 2013 Pages: 11 - 11
Acne prescribing moving towards isotretinoin, worth the extra risk News item 30 January 2013 Pages: 12 - 12
Telithromycin lowers resource use in chronic bronchitis Clinical study 30 January 2013 Pages: 12 - 12
Adalimumab provides “clinically important” HRQOL gains in RA Clinical study 30 January 2013 Pages: 13 - 13
Aggressive treatment of heart failure decreases costs and hospitalisation Clinical study 30 January 2013 Pages: 13 - 13
Montelukast reduces inflammation, improves QOL in asthma Clinical study 30 January 2013 Pages: 13 - 13
Moxifloxacin, nonstandardised antibacterials equivalent in CAP Clinical study 30 January 2013 Pages: 13 - 13
Pfizer aims to appeal ruling over price capping for atorvastatin News item 30 January 2013 Pages: 14 - 14
TNF-α inhibitor market will be dominated by adalimumab, etanercept Media release 30 January 2013 Pages: 14 - 14